Pharm II: Exam #2

0.0(0)
studied byStudied by 2 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/137

flashcard set

Earn XP

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

138 Terms

1
New cards
Bevacizumab Therapeutic Class
Antineoplastic
2
New cards
Bevacizumab Pharmacologic Class
* angiogenesis inhibitor


* monoclonal antibody
* vascular endothelial growth factor (VEGF) inhibitor
* antineoplastic agent

\
block the growth of blood vessels that support tumor growth rather than blocking the growth of tumor cells themselves
3
New cards
Bevacizumab Action
binds to VEGF which prevents endothelial cell proliferation (reproduction) and formation of new blood vessels which suppresses tumor growth
4
New cards
Bevacizumab Use
* colorectal cancer
* lung cancer
* glioblastoma
* renal cancer
5
New cards
Bevacizumab Adverse Effects
* GI perforation
* Hemorrhage
* Wound dehiscence
* Arterial thrombotic events
* Hypertensive Crisis
6
New cards
Bevacizumab Nursing Care
* monitor for adverse effects
* look for infusion reactions
* have pt report syncope dyspnea or edema in legs/abdomen
* illogical thinking
* rash
7
New cards
Cyclophosphamide Therapeutic Class
Antineoplastic
8
New cards
Cyclophosphamide Pharmacologic Class
Alkylating agent, nitrogen mustard
9
New cards
Cyclophosphamide Route
PO or IV
10
New cards
Cyclophosphamide Action
Attaches to DNA and disrupts replication

* cell death occurs when the cell attempts to divide
11
New cards
Cyclophosphamide Use
* leukemia


* multiple myeloma
12
New cards
Cyclophosphamide Adverse Effects
Toxic to tissues with high growth fraction

* **Dermatologic**: alopecia 3-6 weeks after therapy, hair will usually regrow
* **Fertility**: may cause sterility
* **Gastrointestinal**: nausea & vomiting, anorexia, diarrhea, mucositis and stomatitis
* **Hematologic:** thrombocytopenia, anemia, leukopenia

\
13
New cards
Cyclophosphamide Nursing Considerations
* May be toxic to heart and kidney
* Risk of severe, potentially fatal hemorrhagic cystitis (7-40%)
* May cause secondary malignancies or severe infections/sepsis
* Vesicant/extravasation risk: monitor infusion site
* Hazardous agent: use precautions disposing of drug
* Monitor CBC, platelets, BUN, UA, Creatinine
* Keep patient well hydrated to decrease renal damage
* Numerous drug-to-drug interactions especially with St. John’s Wort
14
New cards
Methotrexate Therapeutic Class
Antineoplastic
15
New cards
Methotrexate Pharmacologic Class
Antimetabolite, folic acid analog
16
New cards
Methotrexate Action
closely resembles normal folic acid metabolites, acts as a “counterfiet” that fools the cell and stops cell division
17
New cards
Methotrexate Use
* acute lymphatic
* leukemia
* cancer of colon, breast, stomach, and pancreas
* Rheumatoid Arthritis
* Etopic pregnancy
18
New cards
Methotrexate BBW
* acute renal failure
* bone marrow suppression
* anemia
* leukopenia
* neutropenia
* thrombocytopenia
* fatal skin reactions
* diarrhea
* stomatitis
* death from hemorrhage
* fatal infections
* hepatotoxicity
19
New cards
Methotrexate Nursing Care
* monitor for adverse effects
* discuss signs and symptoms of neutropenia
* Nadir 7-10 days
20
New cards
Doxorubicin Therapeutic Class
Antineoplastic
21
New cards
Doxorubicin Pharmacologic Class
antitumor antibiotic
22
New cards
Doxorubicin Action
inhibits DNA and RNA synthesis and results in cell death
23
New cards
Doxorubicin Use
* solid tumors
* ovarian cancer
* multiple myeloma
* Kaposi’s sarcoma
* Hodgkin’s disease
* non-Hodgkin’s lymphoma
* Leukemia
24
New cards
Doxorubicin Route
IV only into body cavity
25
New cards
Doxorubicin Side Effects
* bone marrow depression
* nausea/vomiting
* alopecia
* stomatitis
* heart failure
* septic shock
26
New cards
Doxorubicin BBW
* myelosuppression
* irreversible cardiotoxicity
* heart failure
* arrhythmias
27
New cards
Doxorubicin Nursing Care
monitor for septicemia and extravasation at injection site or ulceration

* wash hands with soap and water if exposure occurs
28
New cards
Vincristine Therapeutic Class
Antineoplastic
29
New cards
Vincristine Pharmacologic Class
vinca alkaloid

* from vinca rosea plant
30
New cards
Vincristine Action
blocks cellular mitosis (M-phase specific)

* decreases cell replication
* interferes with cell division
31
New cards
Vincristine Use
in combo for…

* Hodgkin’s or non-Hodgkin’s lymphoma


* leukemia
* Wilms tumor
32
New cards
Vincristine BBW
vesicant, avoid extravasation (leakage of blood into tissue from vessel)
33
New cards
Vincristine Nursing Considerations
* constipation
* paralytic ileus
* intestinal necrosis or perforation
* all pts should be on prophylactic bowel management regimen
34
New cards
Tamoxifen Therapeutic Class
Antineoplastic agent
35
New cards
Tamoxifen Pharmacologic Class
hormonal antagonist
36
New cards
Tamoxifen Action
blocks estrogen receptors in some tissues and slows tumor growth

* estrogen receptors are over-expressed in many breast cancers
37
New cards
Tamoxifen Use
* metastatic breast cancer
* prophylactically for those who are high risk for breast cancer
38
New cards
Tamoxifen Side Effects
* not cytotoxic so less side effects
* nausea/vomiting
* hot flashes
* hypercalcemia
* jaundice
* vaginal dryness
39
New cards
Tamoxifen BBW
* increased incidence of uterine or endometrial cancers (report abnormal vaginal bleeding)
* stroke
* pulmonary emboli (use cautiously in those with thromboembolic events)
40
New cards
Epoetin alfa Class
erythropoiesis stimulating drug
41
New cards
Epoetin alfa Action
stimulates RBC production in bone marrow when matured

* results in elevated Hgb and Hct
42
New cards
Epoetin alfa Use
anemia due to chemotherapy
43
New cards
Epoetin alfa Route
SQ 3x/week for 2-6 weeks

* do not shake vial
44
New cards
Epoetin alfa Side Effects
* hypertension
* seizures
* thrombosis
* headache
* nausea
* angina
45
New cards
Epoetin alfa BBW
* thromboembolic events (TIA, MI, DVT)
46
New cards
Epoetin alfa Contraindications
* with myeloid leukemia, may increase tumor growth
47
New cards
Filgrastim Class
leukopoietic growth factor

* stimulates neutrophil production
48
New cards
Filgrastim Action
increases neutrophil production and enhances phagocytic and cytotoxic functions of existing neutrophils
49
New cards
Filgrastim Use
chemotherapy induced neutropenia

* decrease risk of infection
* use only in myeloid malignancies

\
50
New cards
Filgrastim Route
IV or SQ
51
New cards
Filgrastim Adverse Effects
* bone pain
* leukocytosis (WBC > 100,000/mm3)
52
New cards
Filgrastim Nursing Care
* do not give within 24hrs of chemo
* monitor CBC prior to treatment
53
New cards
Ondansetron (Zofran) Therapeutic Class
Antiemetic
54
New cards
Ondansetron Pharmacologic Class
5-HT3 serotonin receptor antagonist
55
New cards
Ondansetron Use
* indicated for prevention of CINV


* radiation induced emesis
* post-operative nausea/vomiting
* hyperemesis gravium
56
New cards
Ondansetron Action
blocks 5-HT3 receptors on vagal nerve terminals and chemoreceptor trigger zone
57
New cards
Ondansetron Route
PO or parenteral
58
New cards
Ondansetron Side Effects
* headache
* sedation
* diarrhea
* constipation
* transient elevations in liver enzymes
59
New cards
Ondansetron Nursing Care
* more effective at preventing CINV than suppressing CINV so should not be given PRN but on a schedule
* give 30min prior to chemo
60
New cards
Ondansetron Caution
Risk for EKG changes

* no single dose should exceed 16mg
61
New cards
Metoclopramide Therapeutic Class
antiemetic
62
New cards
Metoclopramide Pharmacologic Class
* prokinetic
* GI stimulant
63
New cards
Metoclopramide Action
* blocks dopamine receptors and serotonin receptors in chemoreceptor trigger zone of the CNS
* enhances motility and accelerates gastric emptying
64
New cards
Metoclopramide Route
PO or parenteral
65
New cards
Metoclopramide Use
* GERD
* Chemo induced nausea/vomiting
* diabetic gastroparesis
* delayed gastric emptying
* persistent hiccups
66
New cards
Metoclopramide Adverse Effects
**Extrapyramidal**: effects with chronic use = restlessness and anxiety
67
New cards
Metoclopramide BBW
* may cayse tardive dyskinesia (irreversible)
68
New cards
Metoclopramide Nursing Care
* monitor CNS for EPS
* avoid activities requiring mental alertness
* take 30min before meals
69
New cards
Pancrealipase Class
pancreatic enzyme
70
New cards
Pancrealipase Action
enzyme acts locally in the GI tract to help digest fat
71
New cards
Pancrealipase Use
replacement therapy for patients with insufficient pancreatic exocrine secretions

* including pancreatitis and cystic fibrosis
72
New cards
Pancrealipase Nursing Care
* do not crush enteric coated tablets
* powder formulas may be sprinkled in food
* give 1-2hrs before or with meds
73
New cards
Ursodiol Class
gallstone dissolution agent
74
New cards
Ursodiol Indications
* used to dissolve gallstones in patients who do not need to have their gallbladders removed or in those in whom surgery should avoided because of other medical problems
75
New cards
Ursodiol Use
to dissolve gallstones and prevent occurrence for patients losing weight quickly

* may take up to 2 years to dissolve
76
New cards
Ursodiol Action
decreasing the production of cholesterol and by dissolving the cholesterol in bile so that it cannot form stones
77
New cards
Ursodiol Side Effects
* dizziness
* headache
* back pain
* nausea
* constipation
* diarrhea
78
New cards
Ursodiol Nursing Care
* give orally 2-4 times a day
* do not give with aluminum-based antacids (or separate dosage by 2hrs

\
79
New cards
Lactulose Class
osmotic laxative
80
New cards
Lactulose Use
prevention and treatment of portal systemic encephalopathy and consitpation
81
New cards
Lactulose Action
non-digestible synthetic disaccharide that is hydrolyzed in the gut to an osmotically active compound that lowers colonic pH → acidifies colonic contents → favors conversion of NH3 → eliminated into feces

* decreases metabolism of ammonia
* draws H20 into the colon = laxative action → induces defecation
82
New cards
Lactulose Nursing Care
* monitor frequency and consistency of stool
* adjust dose based on diarrhea
* monitor ammonia levels
83
New cards
Metronidazole Class
anti-infective and antiprotozoan
84
New cards
Metronidazole Action
* lethal to anaerobic organisms
* Interacts with DNA to cause strand breakage that result in inhibition of nucleic acid synthesis resulting in cell death
85
New cards
Metronidazole Use
* Used in combination with clarithromycin or tetracycline to treat H-pylori in PUD


* Used to treat c-difficile infections causing diarrhea.
86
New cards
Metronidazole Side Effects
* nausea
* anorexia
* metallic taste
* diarrhea
* can cause bone marrow suppression
87
New cards
Metronidazole Contraindicated
* pts w/ blood dyscrasias
* anemias
* blood disorders
88
New cards
Metronidazole Nursing Care
* take on empty stomach
* may cause drug upset
* monitor side effects
89
New cards
Metronidazole Caution
* liver impairment
* may result in super-infection such as C.diff
90
New cards
Ranitidine Therapeutic Class
antiulcer drug
91
New cards
Ranitidine Pharmacologic Class
(H2 receptor) histamine antagonist
92
New cards
Ranitidine Actions
reduce acid production, blocking H2 receptors in stomach (parietal cells)
93
New cards
Ranitidine Admin
* gastric ulcers take 4-8 weeks to heal


* might be taken long term to prevent recurrence of ulcer
94
New cards
Ranitidine Adverse Effects
* can cause rare blood disorders so use for as short time as possible
* may cause B12 deficiency
95
New cards
Omeprazole Therapeutic Class
antiulcer drug
96
New cards
Omeprazole Pharmacologic Class
proton pump inhibitor
97
New cards
Omeprazole Actions
reduce acid secretion by binding to H+K+- ATPase (pump that releases acid)

* work better than H2 blockers and longer duration of action
* short term therapy for peptic ulcers (4-8 weeks)
* if used longer, increased osteoporosis risk
98
New cards
Omeprazole Use
* used for pts w/ GERD and erosive esophagitis

99
New cards
Omeprazole Admin
Give 30min before meal

* many give once daily
100
New cards
Omeprazole Adverse Effects
* can cause rare blood disorders so use for a short time as possible


* may cause B12 deficiency
* headache
* nausea
* diarrhea (c-difficele)
* Increased risk of pneumonia
* Increased osteoporosis risk and hypomagnesemia in long-term use
* Drug-drug effects with medications used to treat AIDS/HIV and antifungal. Reduces effectiveness of clopidogrel.